123 related articles for article (PubMed ID: 16777992)
1. Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk.
Kaufmann WK; Filatov L; Oglesbee SE; Simpson DA; Lotano MA; McKeen HD; Sawyer LR; Moore DT; Millikan RC; Cordeiro-Stone M; Carey LA
Carcinogenesis; 2006 Dec; 27(12):2519-27. PubMed ID: 16777992
[TBL] [Abstract][Full Text] [Related]
2. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study.
Broeks A; Braaf LM; Huseinovic A; Nooijen A; Urbanus J; Hogervorst FB; Schmidt MK; Klijn JG; Russell NS; Van Leeuwen FE; Van 't Veer LJ
Breast Cancer Res; 2007; 9(2):R26. PubMed ID: 17428320
[TBL] [Abstract][Full Text] [Related]
3. Histopathological features of breast cancer in carriers of ATM gene variants.
Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
[TBL] [Abstract][Full Text] [Related]
4. Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers.
Gutiérrez-Enríquez S; Ramón Y Cajal T; Alonso C; Corral A; Carrasco P; Cornet M; Sanz J; Ribas M; Baiget M; Diez O
Breast Cancer Res Treat; 2011 Jun; 127(3):611-22. PubMed ID: 20625817
[TBL] [Abstract][Full Text] [Related]
5. ATM requirement in gene expression responses to ionizing radiation in human lymphoblasts and fibroblasts.
Innes CL; Heinloth AN; Flores KG; Sieber SO; Deming PB; Bushel PR; Kaufmann WK; Paules RS
Mol Cancer Res; 2006 Mar; 4(3):197-207. PubMed ID: 16547157
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants associated with breast-cancer risk.
Narod SA
Lancet Oncol; 2011 May; 12(5):415-6. PubMed ID: 21514220
[No Abstract] [Full Text] [Related]
7. Phosphorylation of serine 1387 in Brca1 is specifically required for the Atm-mediated S-phase checkpoint after ionizing irradiation.
Xu B; O'Donnell AH; Kim ST; Kastan MB
Cancer Res; 2002 Aug; 62(16):4588-91. PubMed ID: 12183412
[TBL] [Abstract][Full Text] [Related]
8. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
[TBL] [Abstract][Full Text] [Related]
9. The genetic epidemiology of breast cancer genes.
Thompson D; Easton D
J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):221-36. PubMed ID: 15557796
[TBL] [Abstract][Full Text] [Related]
10. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
11. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
[TBL] [Abstract][Full Text] [Related]
13. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM;
Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer.
Xia F; Powell SN
Semin Radiat Oncol; 2002 Oct; 12(4):296-304. PubMed ID: 12382188
[TBL] [Abstract][Full Text] [Related]
15. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal mutagen sensitivity associated with mutations in BRCA genes.
Speit G; Trenz K
Cytogenet Genome Res; 2004; 104(1-4):325-32. PubMed ID: 15162060
[TBL] [Abstract][Full Text] [Related]
17. Screening for ATM sequence alterations in African-American women diagnosed with breast cancer.
Hirsch AE; Atencio DP; Rosenstein BS
Breast Cancer Res Treat; 2008 Jan; 107(1):139-44. PubMed ID: 17333338
[TBL] [Abstract][Full Text] [Related]
18. [Familial breast cancer, ovarian cancer].
Inoue M
Nihon Rinsho; 2006 Jun; Suppl 2():366-70. PubMed ID: 16817423
[No Abstract] [Full Text] [Related]
19. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry.
Bernstein JL; Teraoka S; Southey MC; Jenkins MA; Andrulis IL; Knight JA; John EM; Lapinski R; Wolitzer AL; Whittemore AS; West D; Seminara D; Olson ER; Spurdle AB; Chenevix-Trench G; Giles GG; Hopper JL; Concannon P
Hum Mutat; 2006 Nov; 27(11):1122-8. PubMed ID: 16958054
[TBL] [Abstract][Full Text] [Related]
20. Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study.
Bernstein JL; Langholz B; Haile RW; Bernstein L; Thomas DC; Stovall M; Malone KE; Lynch CF; Olsen JH; Anton-Culver H; Shore RE; Boice JD; Berkowitz GS; Gatti RA; Teitelbaum SL; Smith SA; Rosenstein BS; Børresen-Dale AL; Concannon P; Thompson WD;
Breast Cancer Res; 2004; 6(3):R199-214. PubMed ID: 15084244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]